BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michel M, Kaps L, Maderer A, Galle PR, Moehler M. The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy. Cancers (Basel) 2021;13:2296. [PMID: 34064974 DOI: 10.3390/cancers13102296] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Lawler T, Su T, Cai Q, Steinwandel MD, Zheng W, Blot WJ, Warren Andersen S. Associations between serum vitamin D biomarkers and tumor expression of Ki67, p53, and COX-2 in colorectal cancer cases from the Southern Community Cohort Study. The Journal of Steroid Biochemistry and Molecular Biology 2023;225:106201. [DOI: 10.1016/j.jsbmb.2022.106201] [Reference Citation Analysis]
2 Qiao C, Wang H, Guan Q, Wei M, Li Z. Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: insights and future perspectives. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.09.002] [Reference Citation Analysis]
3 Kealey J, Düssmann H, Llorente-folch I, Niewidok N, Salvucci M, Prehn JHM, D’orsi B. Effect of TP53 deficiency and KRAS signaling on the bioenergetics of colon cancer cells in response to different substrates: A single cell study. Front Cell Dev Biol 2022;10:893677. [DOI: 10.3389/fcell.2022.893677] [Reference Citation Analysis]
4 Sivarajah S, Emerick K, Kaufman HL. What Surgeons Need to Know About Gene Therapy for Cancer. Adv Surg 2022;56:151-68. [PMID: 36096566 DOI: 10.1016/j.yasu.2022.02.006] [Reference Citation Analysis]
5 Flores-López BA, Ayala-Madrigal ML, Moreno-Ortiz JM, Peregrina-Sandoval J, Trujillo-Rojas MÁ, Venegas-Rodríguez JL, Hernández-Ramírez R, Fernández-Galindo MA, Gutiérrez-Angulo M. Molecular Profiling of Tumor Tissue in Mexican Patients with Colorectal Cancer. Curr Issues Mol Biol 2022;44:3770-8. [PMID: 36005154 DOI: 10.3390/cimb44080258] [Reference Citation Analysis]
6 Zheng P, Lv Y, Mao Y, Shen F, Zhang Z, Chang J, Yu S, Ji M, Feng Q, Xu J. High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer. Cancers 2022;14:3843. [DOI: 10.3390/cancers14163843] [Reference Citation Analysis]
7 Ji S, Long S, Yang Y, Liu Z, Wang R, Zhang H, Zhang S. Network Pharmacology and Molecular Docking on the Molecular Mechanism of Jiawei-Huang Lian-Gan Jiang Decoction in the Treatment of Colorectal Adenomas. Evid Based Complement Alternat Med 2022;2022:8211941. [PMID: 35899228 DOI: 10.1155/2022/8211941] [Reference Citation Analysis]
8 Thanki KK, Johnson P, Higgins EJ, Maskey M, Phillips C, Dash S, Almenas FA, Govar AA, Tian B, Villéger R, Beswick E, Wang R, Szabo C, Chao C, Pinchuk IV, Hellmich MR, Módis K. Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102417] [Reference Citation Analysis]
9 Yu L, Zhang MM, Hou JG. Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players. Scand J Gastroenterol 2022;:1-12. [PMID: 35732586 DOI: 10.1080/00365521.2022.2088247] [Reference Citation Analysis]
10 Mukherji R, Weinberg BA, Pedersen KS. Immunotherapy for Colorectal Cancer. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2022.02.010] [Reference Citation Analysis]
11 Carlsen L, Huntington KE, El-deiry WS. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022;14:1028. [DOI: 10.3390/cancers14041028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Oliveira LFS, Predes D, Borges HL, Abreu JG. Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer. Cancers 2022;14:403. [DOI: 10.3390/cancers14020403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Zhang Y, Zhang X, Jin Z, Chen H, Zhang C, Wang W, Jing J, Pan W. Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression. J Inflamm Res 2021;14:5403-17. [PMID: 34737598 DOI: 10.2147/JIR.S331010] [Reference Citation Analysis]
14 Piipponen M, Riihilä P, Nissinen L, Kähäri VM. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4507. [PMID: 34572732 DOI: 10.3390/cancers13184507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Koushki M, Khedri A, Aberomand M, Akbari Baghbani K, Mohammadzadeh G. Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carcinoma MCF-7 and MDA-MB-231 cell lines. Iran J Basic Med Sci 2021;24:1211-9. [PMID: 35083008 DOI: 10.22038/ijbms.2021.56341.12575] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Sadeghi-abandansari H, Pakian S, Nabid M, Ebrahimi M, Rezalotfi A. Local co-delivery of 5-fluorouracil and curcumin using Schiff's base cross-linked injectable hydrogels for colorectal cancer combination therapy. European Polymer Journal 2021;157:110646. [DOI: 10.1016/j.eurpolymj.2021.110646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
17 Shaath H, Toor SM, Nada MA, Elkord E, Alajez NM. Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer. Sci Rep 2021;11:14456. [PMID: 34262080 DOI: 10.1038/s41598-021-93531-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Rathore M, Wright M, Bhattacharya R, Fan F, Vaziri-gohar A, Winter J, Wang Z, Markowitz SD, Willis J, Ellis LM, Wang R. Liver Endothelium Promotes HER3-mediated Cell Survival in KRAS Wild-type and Mutant Colorectal Cancer Cells.. [DOI: 10.1101/2021.04.27.441690] [Reference Citation Analysis]